Amgen Inc.
Approved Evidence
Amgen paid $24.75 million over Medicare copay foundation kickback allegations
DOJ alleged Amgen used a purportedly independent foundation to cover Medicare patients' copays for its products, generating Medicare claims while undermining statutory cost controls. Amgen agreed to pay $24.75 million to resolve the allegations. Source: https://www.justice.gov/archives/opa/pr/two-pharmaceutical-companies-agree-pay-total-nearly-125-million-resolve-allegations-they-paid
Amgen pleaded guilty and paid $762 million over illegal drug marketing and False Claims Act allegations
Amgen pleaded guilty to introducing misbranded Aranesp into interstate commerce and agreed to a $762 million global criminal and civil resolution. DOJ said the civil component also resolved allegations involving off-label promotion, kickbacks and false price reporting. Source: https://www.justice.gov/archives/opa/pr/amgen-inc-pleads-guilty-federal-charge-brooklyn-ny-pays-762-million-resolve-criminal